Lilly Product Information

As part of our long-standing commitment to diabetes care, Lilly provides patients with breakthrough treatments that help them to live full and active lives.

Since 1923, Lilly has been the industry leader in pioneering therapies to help healthcare professionals improve the lives of people with diabetes, and research continues on innovative medicines to address the unmet needs of patients.

To learn more about a Lilly product, click on the links below:

• Humalog^® Brand of Insulins

  Humalog^® (insulin lispro injection [rDNA origin])

  Humalog^® Mix75/25™ (75% insulin lispro protamine suspension, 25% insulin lispro injection [rDNA origin])

  Humalog^® Mix50/50™ (50% insulin lispro protamine suspension, 50% insulin lispro injection [rDNA origin])

  Select Safety Information
  The most common side effect associated with the use of all insulins, including the Humalog Brand of Insulins, is low blood sugar. Other side effects may include weight gain, low blood potassium, changes in fat tissue at the site of injection, and allergic reactions, both general and local. Starting or changing insulin therapy should be done cautiously and only under medical supervision. For additional safety information, please see Important Safety Information and Humalog Patient Information.

• Humulin^® Brand of Insulins

  Humulin^® R (REGULAR human insulin injection [rDNA origin])

  Humulin^® N (NPH human insulin injection [rDNA origin])

  Humulin^® 70/30 (70% human insulin isophane suspension, 30% human insulin injection [rDNA origin])

  Humulin^® 50/50 (50% human insulin isophane suspension, 50% human insulin injection [rDNA origin])

Please note! Humulin^® R Regular U-500 (Concentrated) insulin human injection, USP (rDNA Origin) is a stronger concentration (500 units/mL) of Humulin R. Please read the Prescribing Information for proper dosage and administration.

• Insulin Pens
• Glucagon for Injection (rDNA origin)

HI52648